Spots Global Cancer Trial Database for grade i meningioma, adult
Every month we try and update this database with for grade i meningioma, adult cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
---|---|---|---|---|---|---|
Stereotactic Radiosurgery and Immunotherapy (Pembrolizumab) for the Treatment of Recurrent Meningioma | NCT04659811 | Grade I Meningi... Grade II Mening... Grade III Menin... Recurrent Menin... | Pembrolizumab Stereotactic Ra... | 18 Years - | University of California, San Francisco |